Alacrita is life science consulting for a networked age. You can expect the caliber and capabilities of a top-ranked consulting firm, but you'll find a difference in our expertise. We've built our team carefully, hand-picking only those consultants with deep domain knowledge and senior business experience. With more than 200 successful client assignments each year, we're proving what's possible for commercial life sciences in a new era of opportunity.
Simon TurnerManaging Partner
Exhibiting at booth 4
The Almac Group is an established contract development and manufacturing organisation that provides the most unique range of integrated drug development services available to the pharmaceutical & biotech industry.
We are a privately owned organisation that has organically grown over 50 years and now employs in excess of 5,000 high skilled personnel. Almac is headquartered in Craigavon, Northern Ireland with 17 global facilities across Europe, USA and Asia.
Our quality, innovation and efficiency are testament to the fact that over 600 companies worldwide trust Almac for their Chemical, Pharmaceutical and Clinical Development needs.
Addressing the increasing pressure for Biopharma companies to bring their clinical candidates through their pipeline faster, more efficiently and at a lower cost, Almac provides an integrated CMC service, bridging the gap between drug substance and drug product development.
As an established provider of both drug substance (advanced intermediates and Active Pharmaceutical Ingredients – small molecules and peptides) and drug product development services, and by offering these within an integrated package, our client partners are assured of scientific continuity from a dedicated project team, resulting in significant savings in both time and costs.
Franciane ChevotBusiness Development Manager
Renato NatiliBusiness Development manager
ApconiX are experts in ion channel biology, target safety assessments and in all aspects of nonclinical programme design and delivery.
ApconiX was formed by three AstraZeneca colleagues with the drive and ambition to create a world-renowned company founded on the skills and experience of a growing team with a wide range of expertise in nonclinical drug safety.
The model for the pharmaceutical industry has evolved in recent years with large pharma reducing internal capability and outsourcing key skills to trusted partners. There are many more SMEs and academic groups who also need access to specialised services.
ApconiX addresses all needs by providing an exceptional group of scientists to these companies, in a cost-effective and flexible way. In this way, companies work with people they trust, to make better decisions on drug safety.
Aptus Clinical is a specialist UK-based Clinical Contract Research Organisation (CRO) with particular expertise in oncology, rare diseases and advanced, cell and gene therapies. We have decades of experience in delivering complex and innovative trials, transforming potential into value.
We are proud to be part of iMATCH, a Manchester-based consortium which is one of only three centres in the UK to be awarded funding by Innovate UK to coordinate scale-up of advanced therapies for a range of debilitating conditions.
In partnering with life science companies, we can help transform promising molecules into valued medicines. We ensure early clinical development strategies are optimised and that Phase I/II studies are both innovatively designed and expertly delivered.
Jonathan LewisBusiness Development Director
Julia YoungBusiness Development Manager
Arcinova is a UK based Contract Research and Development Organisation (CRDO) operating from a 15,000m2 site which has benefited from more than 36 years of investment as a key research and development centre. We provide the pharmaceutical industry with a comprehensive range of services, backed by extensive scientific expertise and strong practical capabilities.
We work to enhance the health and wellbeing of society by helping companies to develop life changing medicines and take them to market quickly, effectively and efficiently.
Our focus is on API process research, the development, validation and application of analytical, microbiological and materials science spectroscopic methodologies, scale-up and early phase clinical product manufacturing. We provide non-clinical and clinical 14C, API, drug product, bioanalysis, regulatory and consulting services.
Our mission at Arcinova is to delight our life sciences customers by satisfying their contract research, development and manufacturing needs with agility, innovation, seamless teamwork and best value delivery.